Surging Incidence Of Kidney Diseases Fuels Growth In The Kidney Disease Market Emerges as a Core Driver of the Kidney Disease Market in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Kidney Disease Market Through 2025?
In recent times, the scale of the kidney disease sector has experienced significant expansion, projected to increase from its 2024 valuation of $107.29 billion to $114.39 billion by 2025, reflecting a compound annual growth rate of 6.6%; this historical upward trend is fundamentally linked to the proliferation of ongoing health issues, the increasing average age of the populace, inherited risk factors, advancements in medical investigation and learning, and various ecological influences.

What's the Projected Size of the Global Kidney Disease Market by 2029?
Forecasting robust expansion, the kidney disease sector's market valuation is projected to reach $148.77 billion by 2029, demonstrating a compound annual growth rate of 6.8% throughout this period, a surge fueled by the worldwide management of infectious diseases, the adoption of personalized medicine strategies, the escalating issues of diabetes and obesity, evolving healthcare policies, and heightened public awareness coupled with improved screening efforts; concurrently, significant shifts shaping this market involve the increasing use of telemedicine for renal treatment, a greater emphasis on preventative nephrology, the expansion of dialysis services conducted at home, advancements in regenerative treatment modalities, and the growing importance given to nutritional adjustments and dietary changes.

View the full report here:
https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Top Growth Drivers in the Kidney Disease Industry: What's Accelerating the Market?
Anticipated rises in kidney illness occurrences are set to fuel the expansion of the kidney disease market in the future.Kidney ailments encompass various ailments impacting the functional capacity and physical makeup of the kidneys.Pharmaceutical agents designed for kidney disorders serve to decrease patient hypertension and minimize protein leakage, thereby decelerating the advancement of renal harm, controlling associated symptoms, and averting secondary issues.To illustrate this trend, data released in June 2023 by Kidney Research UK, a British charity dedicated to research and campaigning aimed at bettering the comprehension, avoidance, and care of kidney conditions, suggested that approximately 7.19 million individuals across the UK were living with chronic kidney disease that year, a figure surpassing one-tenth of the UK populace, with projections indicating this number will climb to 7.61 million by 2033.Consequently, this heightened prevalence of kidney pathologies acts as a catalyst for the expanding kidney disease market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11938&type=smp

What Trends Will Shape the Kidney Disease Market Through 2029 and Beyond?
A significant movement observed within the sector for kidney ailments involves incorporating artificial intelligence powered instruments, a tendency that is currently on the rise. To enhance results for those affected by kidney conditions and to secure their competitive standing, various firms engaged in this market are embracing novel technological advancements. A prime illustration of this is the release in November of 2022 by Carenostics, a US-based newcomer focused on AI applications in healthcare, which debuted its initial offering engineered for the early detection of chronic kidney disease (CKD) through the examination of electronic health record (EHR) information. Carenostics effectively embeds its AI-based clinical guidance mechanisms directly into the existing EHR platforms utilized by healthcare facilities, thereby equipping medical professionals with the ability to precisely pinpoint individuals facing elevated risks from chronic conditions and facilitate timely, preventative interventions aimed at yielding superior patient welfare.

What Are the Main Segments in the Kidney Disease Market?
The kidney diseasemarket covered in this report is segmented -

1) By Treatment: Medication; Dialysis; Surgery; Other Treatments
2) By Indication: Acute Kidney Injury; Chronic Kidney Disease; End-Stage Renal Disease; Other Indication
3) By Route Of Administration: Oral; Parenteral
4) By End-User: Hospitals; Diagnostic Laboratories; Other End-Users

Subsegments:
1) By Medication: Antihypertensives; Erythropoiesis-Stimulating Agents (ESAs); Phosphate Binders; Vitamin D Analogs; Immunosuppressants
2) By Dialysis: Hemodialysis; Peritoneal Dialysis
3) By Surgery: Kidney Transplant; Nephrectomy; Renal Artery Bypass; Ureteral Surgery
4) By Other Treatments: Lifestyle And Dietary Modifications; Renal Replacement Therapy; Palliative Care

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11938&type=smp

Which Top Companies are Driving Growth in the Kidney Disease Market?
Major companies operating in the kidney disease market include Pfizer Inc., Johnson & Johnson Ltd., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi Aventis LLC, Bristol-Myers Squibb Company, AstraZeneca Pharmaceuticals LP, Abbott Laboratories, Fresenius SE & Co. KGaA, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Vertex Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Kyowa Kirin Co. Ltd., Cipla Inc., Endo International plc., Lupin Limited, Kissei Pharmaceutical Co. Ltd.

Which Regions Will Dominate the Kidney Disease Market Through 2029?
North America was the largest region in the kidney disease market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11938

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.